Private Equity Firm Healthcare

Perceptive Advisors

New York, New York, United States

Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.

Focus Areas
Life Sciences, Healthcare, Biotechnology

Tracked deals

5

5 tracked deals across 2020-2026.

Recent pace

4

4 tracked deals announced in the last 12 months.

Deal mix

Buyout

5 buyout

Perceptive Advisors Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Perceptive Advisors. 1 2020 1 2025 ~4 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Lisata Therapeutics Acquires Marea Therapeutics in Stock-for-Stock Deal and Concurrent $225M Private Placement
    September 17, 2026
    Buyer
    Lisata Therapeutics, Inc., RA Capital Management, Forbion, Third Rock Ventures, Alpha Wave, Perceptive Advisors, Sofinnova Investments, Omega Funds, Surveyor Capital (a Citadel company), Columbia Threadneedle Investments, Nantahala Capital, Affinity Asset Advisors, LLC, venBio, Rock Springs Capital
    Target
    Marea Therapeutics, Inc.
    Industry
    Pharmaceuticals
    Location
    United States
    Type
    Buyout

    Lisata Therapeutics acquired Marea Therapeutics in a stock-for-stock transaction to build a combined portfolio focused on next-generation medicines for cardioendocrine diseases. Concurrently, Lisata raised $225 million through an oversubscribed private placement with leading life sciences and institutional investors to fund clinical milestones into 2028.

  • DocGo Signs Definitive Agreement to Acquire Hicuity Health
    August 17, 2026
    Buyer
    DocGo Inc., Perceptive Advisors
    Target
    Hicuity Health
    Industry
    Healthcare Services
    Location
    United States
    Type
    Buyout

    DocGo has entered into a definitive agreement to acquire Hicuity Health, a virtual care provider offering high acuity virtual clinical services including Tele-ICU and virtual nursing. DocGo will acquire Hicuity in exchange for assuming Hicuity’s existing indebtedness (held by Perceptive Advisors) and Perceptive Advisors will also commit additional debt financing to DocGo.

  • InMed Pharmaceuticals to Merge with Mentari Therapeutics in $290M All-Stock Deal
    May 20, 2026
    Buyer
    InMed Pharmaceuticals, Inc., Fairmount, Commodore Capital, Deep Track Capital, Janus Henderson Investors, a16z Bio + Health, Venrock Healthcare Capital Partners, Wellington Management, TCGX, Blackstone Multi-Asset Investing, BB Biotech, Farallon Capital, RTW Investments, Vivo Capital, Perceptive Advisors, Sirenia Capital Management LP, Oruka Therapeutics (Oruka Therapeutics executive board involvement)
    Target
    Mentari Therapeutics, Inc.
    Industry
    Biotechnology
    Location
    United States
    Type
    Buyout

    InMed Pharmaceuticals (NASDAQ: INM) entered into a definitive all-stock merger agreement with privately held Mentari Therapeutics, creating a publicly traded migraine-focused biotech under the Mentari name. The transaction is supported by an oversubscribed $290 million private placement led by Fairmount to fund operations through 2028.

  • Perceptive Capital Solutions Corp and Freenome Merge in ~$330M SPAC Deal to Create Publicly Listed Freenome, Inc.
    December 7, 2025
    Buyer
    Perceptive Capital Solutions Corp (PCSC), Perceptive Advisors, RA Capital
    Target
    Freenome Holdings, Inc., StarNet Merger Sub I, Corp., StarNet Merger Sub II, LLC
    Industry
    AI & Machine Learning
    Location
    California, United States
    Type
    Buyout

    Perceptive Capital Solutions Corp (PCSC) and Freenome Holdings agreed to merge in a SPAC transaction that is expected to take the cancer-detection company public, providing approximately $330 million in fresh capital (assuming no redemptions). The deal includes a $240 million PIPE led by Perceptive Advisors and RA Capital and is expected to close in the first half of 2026 / July 2026 subject to approvals and customary conditions.

  • Omada Health Acquires Physera
    May 19, 2020
    Buyer
    Omada Health, Perceptive Advisors
    Target
    Physera
    Industry
    Healthcare Services
    Location
    California, United States
    Type
    Buyout

    Omada Health has acquired Physera, a digital musculoskeletal (MSK) care provider, to add virtual physical therapy and MSK management to Omada’s suite of digital chronic-care programs. Omada raised growth capital from Perceptive Advisors to finance the acquisition and accelerate integration of Physera’s telehealth and digital exercise therapy capabilities into its offerings for employers, health plans, and consumers.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 2 tracked deals by Perceptive Advisors. AI & Machine Learning Buyers & Acquisitions 1 tracked deal by Perceptive Advisors. Biotechnology Buyers & Acquisitions 1 tracked deal by Perceptive Advisors. Pharmaceuticals Buyers & Acquisitions 1 tracked deal by Perceptive Advisors. Acquisitions in California 2 tracked deals by Perceptive Advisors.

Related articles

Selling a company? Get in front of buyers like Perceptive Advisors

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →